|
|
||||||||

*
Laboratory of Cellular and Molecular Immunology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892; and
Department of Adult Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, 02115
| Abstract |
|---|
|
|
|---|
6 mo. In contrast, mice that
were primed to H-Y just after thymectomy continued to display
immunological memory to H-Y for >1 year. These experiments show that
primary immune responses disappear in the absence of a
thymus. | Introduction |
|---|
|
|
|---|
We decided to re-examine the question of lifespan for several reasons. First, we were uncertain about some of the Ags used in the previous studies. T cells are more cross-reactive than previously realized (11, 12, 13, 14). Thus, many "primary" immunizations might also stimulate a subset of memory cells, previously primed by a cross-reactive environmental Ag. This might account for the patterns seen after thymectomy, where the responses dropped to a certain level (due to the loss of naive cells?) but did not disappear (due to the persistence of the subset of cross-reactively primed memory cells).
Second, we were uncertain about some of the T cells. For example,
studies done with TCR transgenic
(Tg)2 T cells have
often been confounded by the finding that Tg T cells often express a
second endogenous TCR
-chain (15) that may respond to
environmental Ags and thus allow the persistence of cells that would
otherwise die for lack of Ag stimulation (9, 16). In a few
cases, the persistence of naive T cells was studied in Tg mice crossed
to a RAG-/- background, in which no endogenous
TCR chains are made. Although the Ag in this case, H-Y, was appropriate
because it does not appear to have significant environmental
cross-reactants (17, 18, 19), persistence was followed for no
longer than 89 wk (20, 21, 22, 23).
In 1965, Taylor noticed that the alloresponses of thymectomized mice
remained unchanged for
26 wk (2), after which they
began to drop. Therefore, we studied the persistence of responses to
H-Y in normal C57BL/6 (B6) mice for a period of >1 year. In three
separate experiments done over a period of 5 years, we found that
thymectomized mice completely lost the ability to mount a primary
cytotoxic response to H-Y at
6 mo postthymectomy, whereas their
memory response to the same Ag was unaffected. From this, we conclude
that naive cells cannot live indefinitely in the absence of their
cognate Ag.
| Materials and Methods |
|---|
|
|
|---|
B6, AKR, and CBA/J mice (68 wk old) from Taconic Laboratories (Germantown, NY) or Clarence Reeder (National Cancer Institute, Frederick, MD) were housed at the National Institute of Allergy and Infectious Diseases, accredited by the American Association for Accreditation of Laboratory Animal Care.
Adult thymectomy
For series I, we thymectomized the B6 female mice. We anesthetized the mice with 0.30.5 ml of Avertin and made a supra clavicular incision of skin followed by blunt dissection of throat muscle; next, we inserted a blunt suction pipette and removed each individual lobe of the thymus by applying suction. Age-matched controls were similarly sham-thymectomized without removing the thymus. For series II and III, we purchased B6 female mice that had been thymectomized at 68 wk of age at Taconic Laboratories.
Abs and cytofluorometric analysis
We stained for TCR-, CD4-, CD8-, and CD44-positive cells with
anti-TCR-FITC (H57, PharMingen, San Diego, CA), anti-CD4-PE or
-APC (RM4-4, PharMingen), anti-CD8
-Red 613 or -PE (53-6.7, Life
Technologies, Grand Island, NY), and anti-CD44-FITC or -PE (Pgp-1,
IM7, PharMingen) mAbs, followed by analysis with a FACScan or
FACScalibur (Becton Dickinson, San Jose, CA). Each sample was first
incubated with the anti-Fc
R mAb (2.4G2, American Type Culture
Collection, Manassas, VA) (24) to block nonspecific
staining.
In vivo immunization
B6 female mice were immunized by an i.p. injection of 2 x 106 B6 male splenocytes prepared in PBS.
Cytotoxicity tests
Spleen cells from each responder mouse were stimulated in vitro with syngeneic (B6) male or allogeneic (AKR or CBA/J) female spleen cells and tested 5 days later for killing activity by the JAM test (25). Briefly, 46 x 106 responder spleen cells were cultured for 56 days against 2 x 106 irradiated (15003000 rad) stimulator spleen cells in 2 ml of IMDM supplemented with 10% FCS, 50 U/ml penicillin, 50 µg/ml streptomycin sulfate, 50 µg/ml gentamicin sulfate, 4 mM glutamine, and 50 µM 2-ME. At the end of the 5- to 6-day culture, the responders were harvested and tested for cytotoxic activity against [3H]thymidine-labeled B6 male, AKR, CBA/J, or B6 female Con A-activated spleen cell blasts. In some experiments, the cultures were performed either with or without optimal concentrations of conditioned supernatant (rat T-Stim without Con A, Collaborative Biomedical Products, Bedford, MA) as a source of helper factors.
| Results and Discussion |
|---|
|
|
|---|
Fig. 1
shows the numbers and CD44
distribution of T cells in the spleens of normal and thymectomized
mice. Like Swain et al. (26), we found that normal aging
mice maintained fairly stable numbers of
CD44negative/low "naive" cells. This could be
due to two factors. Either 1) the thymic output of naive cells
compensates for losses due to death or to activation of naive cells and
their subsequent movement into the memory pool, or 2) some
CD44high cells revert to a
CD44negative/low phenotype. To discriminate
between these two possibilities, we looked at thymectomized mice and
found that the naive CD44negative/low cells
disappear with time, whereas the CD44high
"memory" pool remains relatively unchanged. Thus, although there
may be a certain amount of conversion from
CD44high to
CD44negative/low, it is not sufficient to
maintain the pool in the absence of a thymus.
|
To determine whether the loss of naive cells in thymectomized mice was due to death or movement to the memory pool, we measured the responses of these mice to H-Y. If naive T cells are becoming memory cells, they should respond well to an injection of male cells; however, if the naive T cells are dying, there should come a point at which they would no longer be able to respond.
In the first series of experiments, we thymectomized or
sham-thymectomized 40 B6 female mice at 6 to 8 wk of age. At various
times afterward, we immunized three to five mice from each group
against B6 male spleen cells and tested them 3 wk later for
anti-H-Y killing activity after a secondary stimulation culture in
vitro. Fig. 2
A shows that the
ability to be primed began to wane at 22 wk; by 26 wk postthymectomy,
the thymectomized mice were almost completely unresponsive to
H-Y.
|
Memory responses to H-Y
To investigate whether thymectomy affects memory responses to H-Y,
we primed normal and thymectomized mice at 5 wk postthymectomy and
tested three to five females from each group at 16, 34, and 54 wk
postthymectomy. Fig. 3
A shows
that these mice still responded strongly 1 year later. These results
suggest that although primary responses to H-Y wane after thymectomy,
memory responses do not.
|
Because the response against allogeneic MHC is directed against a
wide variety of peptide/MHC complexes (28, 29), some of
the responding cells may be preprimed by cross-reactive Ags. The naive
portion of the response should therefore wane in thymectomized mice
while the memory portion remains intact. Fig. 3
B shows that
the anti-CBA/J alloresponses of the B6 thymectomized mice began to
drop at
34 wk postthymectomy; three of five thymectomized mice had a
very weak anti-CBA/J response at 1 year. The variability in decay
among individual thymectomized mice in a group might depend upon
differences in their immunological history. Each mouse maintains its
own idiosyncratic pool of memory cells (13, 30), which
might cross-react or not against allogeneic MHC molecules (11, 12).
Thymus output and aging
Fig. 4
A is a summary of
128 mice tested in three independent series of experiments. Like Taylor
(2), we found that the virgin response remained steady for
the first 45 mo and then rapidly declined. Although anti-MHC
responses were still visible, the anti-H-Y response disappeared
entirely. The response also declined in normal, unthymectomized mice;
however, more than half of these mice remained responsive at the 1-yr
timepoint, suggesting that the thymus continues to contribute to the
primary responses of 1-yr-old normal mice. Fig. 4
, B and
C plot the means of the responses from each 5-wk time period
postthymectomy, showing that memory responses to H-Y did not decline;
anti-allo-MHC responses showed only a small decay in both
thymectomized and control groups.
|
Our data support the first part of a recently suggested scenario in which the virgin and memory T cell pools are independently regulated (31). However, they do not support the second suggestion, that virgin cells have an indefinite lifespan and that the numbers are regulated by a finite number of niches for which circulating naive cells and newly emerging thymocytes compete (9, 10). This view predicts that, if the thymus is removed, the naive cells should last indefinitely at the number set by the number of niches. We found that naive T cells do not have an infinite lifespan (although it is surprisingly long), and that the thymus itself is important to the survival of the naive cell pool. Without it, the pool disappears, both phenotypically and functionally.
How then do normal aging individuals maintain the ability to respond to new Ags? There are at least two possibilities. First, the thymus does not involute completely. Although its output drops in the mouse from 2 x 106/day at 8 wk to 1 x 105/day at 6 mo (32, 33), it continues to export T cells. If any of these cells are new naive T cells, this could contribute 18 million T cells every 6 mo to replace those that are dying. The thymus might also put out soluble factors that contribute to the survival of naive T cells.
Second, memory cells may be far more flexible than is normally supposed. Cross-reactions abound (11, 12, 13, 14). Selin et al. (13) showed that a small proportion of T cells to one virus can be moved to the memory compartment by priming with an unrelated virus, and many cross-reactions have been seen between one peptide/MHC complex and another (11, 12, 34). Thus, the appearance of a new Ag might stimulate cross-reactive memory T cells. Although the primary response to individual peptides (such as H-Y) may disappear with time, most pathogens present a multitude of Ags. Thus, even if the thymus eventually stops producing, the variety of cross-reactive receptors maintained in the memory pool should allow for responsiveness to a wide range of new antigenic challenges.
Finally, why should a thymectomized mouse respond well for months and then suddenly lose this ability? Such a pattern suggests that two interacting cells are approaching limiting numbers at about the same time (35); this possibility fits nicely with our current understanding of Th-CTL interactions, in which it appears that Th cells "educate" APCs and thereby enable them to activate CTL precursors (36, 37, 38). Immediately after thymectomy, there are enough helpers to educate all of the H-Y-presenting APCs. As the number of T cells decreases, the probability that an APC will encounter a helper before it meets a killer will drop. However, the few that do will initiate a response and the drop in frequency will not be noticed. Eventually, the number of T cells will have declined enough so that no APC meets both a helper and a killer and no response can occur. Thus, the response disappears before the last responding cells have died. Our estimate of the lifespan of an H-Y-specific T cell is thus likely to be a slight underestimate. It is nevertheless surprisingly long. Six months is about one quarter of the life of a mouse. It will be interesting to see whether the lifespan of naive T cells in longer-lived species is corresponding lengthened.
| Acknowledgments |
|---|
| Footnotes |
|---|
2 Abbreviations used in this paper: Tg, transgenic, B6, C57BL/6. ![]()
Received for publication March 3, 1999. Accepted for publication May 20, 1999.
| References |
|---|
|
|
|---|
/
T cells in secondary lymphoid organs. J. Exp. Med. 177:891.This article has been cited by other articles:
![]() |
E. Parretta, G. Cassese, A. Santoni, J. Guardiola, A. Vecchio, and F. Di Rosa Kinetics of In Vivo Proliferation and Death of Memory and Naive CD8 T Cells: Parameter Estimation Based on 5-Bromo-2'-Deoxyuridine Incorporation in Spleen, Lymph Nodes, and Bone Marrow J. Immunol., June 1, 2008; 180(11): 7230 - 7239. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Vrisekoop, I. den Braber, A. B. de Boer, A. F. C. Ruiter, M. T. Ackermans, S. N. van der Crabben, E. H. R. Schrijver, G. Spierenburg, H. P. Sauerwein, M. D. Hazenberg, et al. Sparse production but preferential incorporation of recently produced naive T cells in the human peripheral pool PNAS, April 22, 2008; 105(16): 6115 - 6120. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Cassese, E. Parretta, L. Pisapia, A. Santoni, J. Guardiola, and F. Di Rosa Bone marrow CD8 cells down-modulate membrane IL-7R{alpha} expression and exhibit increased STAT-5 and p38 MAPK phosphorylation in the organ environment. Blood, September 15, 2007; 110(6): 1960 - 1969. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Grayson, A. E. Weant, B. C. Holbrook, and D. Hildeman Role of Bim in Regulating CD8+ T-Cell Responses during Chronic Viral Infection. J. Virol., September 1, 2006; 80(17): 8627 - 8638. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Song, Z. Guan, I. E. Gienapp, T. Shawler, J. Benson, and C. C. Whitacre The Thymus Plays a Role in Oral Tolerance in Experimental Autoimmune Encephalomyelitis J. Immunol., August 1, 2006; 177(3): 1500 - 1509. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. E. Miller, J. R. Bonczyk, Y. Nakayama, and M. Suresh Role of Thymic Output in Regulating CD8 T-Cell Homeostasis during Acute and Chronic Viral Infection J. Virol., August 1, 2005; 79(15): 9419 - 9429. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Bourgeois, G. Kassiotis, and B. Stockinger A Major Role for Memory CD4 T Cells in the Control of Lymphopenia-Induced Proliferation of Naive CD4 T Cells J. Immunol., May 1, 2005; 174(9): 5316 - 5323. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-E. Blais, G. Gerard, M. M. Martinic, G. Roy-Proulx, R. M. Zinkernagel, and C. Perreault Do thymically and strictly extrathymically developing T cells generate similar immune responses? Blood, April 15, 2004; 103(8): 3102 - 3110. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Grandjean, L. Duban, E. A. Bonney, E. Corcuff, J. P. Di Santo, P. Matzinger, and O. Lantz Are Major Histocompatibility Complex Molecules Involved in the Survival of Naive CD4+ T Cells? J. Exp. Med., October 6, 2003; 198(7): 1089 - 1102. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Suarez, L. Mozo, and C. Gutierrez Generation of CD4+CD45RA+ Effector T Cells by Stimulation in the Presence of Cyclic Adenosine 5'-Monophosphate- Elevating Agents J. Immunol., August 1, 2002; 169(3): 1159 - 1167. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Ortman, K. A. Dittmar, P. L. Witte, and P. T. Le Molecular characterization of the mouse involuted thymus: aberrations in expression of transcription regulators in thymocyte and epithelial compartments Int. Immunol., July 1, 2002; 14(7): 813 - 822. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Dai and F. G. Lakkis Cutting Edge: Secondary Lymphoid Organs Are Essential for Maintaining the CD4, But Not CD8, Naive T Cell Pool J. Immunol., December 15, 2001; 167(12): 6711 - 6715. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Andrew and R. Aspinall IL-7 and Not Stem Cell Factor Reverses Both the Increase in Apoptosis and the Decline in Thymopoiesis Seen in Aged Mice J. Immunol., February 1, 2001; 166(3): 1524 - 1530. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Murali-Krishna and R. Ahmed Cutting Edge: Naive T Cells Masquerading as Memory Cells J. Immunol., August 15, 2000; 165(4): 1733 - 1737. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Xu, J. Wipasa, H. Yan, M. Zeng, M. O. Makobongo, F. D. Finkelman, A. Kelso, and M. F. Good The Mechanism and Significance of Deletion of Parasite-specific CD4+ T Cells in Malaria Infection J. Exp. Med., April 1, 2002; 195(7): 881 - 892. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |